Hudson Bay Capital Management LP
CIK 0001393825 Name as filed on the most recent filing
Filed as Hudson Bay Capital Management LP (23)· Hudson Bay Capital Management, L.P. (3)
51 transaction lines · from 26 filings · filed 2007-12-05 to 2023-04-27 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Twin Ridge Capital Acquisition Corp. 1 filings
- ISSUER Model Performance Acquisition Corp 1 filings
- ISSUER Yunhong International 1 filings
- ISSUER Tenzing Acquisition Corp. 2 filings
- ISSUER Amci Acquisition Corp. 2 filings
- ISSUER Trident Acquisitions Corp. 2 filings
- ISSUER SCVX Corp. 3 filings
- ISSUER Akers Biosciences, Inc. 3 filings
- ISSUER Longevity Acquisition Corp 2 filings
- ISSUER M I Acquisitions, Inc. 1 filings
- ISSUER Galena Biopharma, Inc. 1 filings
- ISSUER Hc2 Holdings, Inc. 2 filings
- ISSUER 24Holdings Inc 2 filings
- ISSUER EnteroMedics Inc 1 filings
- ISSUER Chem RX Corp 2 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
1 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2023-04-26 |
Twin Ridge Capital Acquisition Corp. TRCA |
S, Open-market sale | 229,746 disposed | 10.31 | 2,368,681.26 | Form 4, filing 0001393825-23-000203 | |
| 2023-04-25 |
Twin Ridge Capital Acquisition Corp. TRCA |
S, Open-market sale | 254 disposed | 10.32 | 2,621.28 | Form 4, filing 0001393825-23-000203 | |
| 2022-10-05 |
Model Performance Acquisition Corp MPAC |
P, Open-market purchase | 6,379 acquired | 10.32 | 65,831.28 | Form 4, filing 0000902664-22-004985 | |
| 2021-10-22 |
Yunhong International ZGYH |
S, Open-market sale | 200,000 disposed | 10.98 | 2,196,000.00 | Form 4, filing 0001393825-21-000094 | |
| 2020-12-07 |
Tenzing Acquisition Corp. TZAC |
S, Open-market sale | 50,000 disposed | 11.51 | 575,500.00 | Form 4, filing 0001393825-20-000141 | |
| 2020-11-27 |
Amci Acquisition Corp. AMCI |
S, Open-market sale | 100,000 disposed | 11.27 | 1,127,000.00 | Form 4, filing 0001393825-20-000136 | |
| 2020-11-02 |
Tenzing Acquisition Corp. TZAC |
S, Open-market sale | 50,000 disposed | 10.87 | 543,500.00 | Form 4, filing 0001393825-20-000131 | |
| 2020-07-13 |
Trident Acquisitions Corp. TDAC |
S, Open-market sale | 346,857 disposed | 10.88 | 3,773,804.16 | Form 4, filing 0001393825-20-000124 | |
| 2020-07-13 |
Trident Acquisitions Corp. TDAC |
S, Open-market sale | 346,857 acquired | 10.88 | 3,773,804.16 | Form 4, filing 0001393825-20-000123 | |
| 2020-07-10 |
Trident Acquisitions Corp. TDAC |
S, Open-market sale | 13,143 disposed | 10.92 | 143,521.56 | Form 4, filing 0001393825-20-000124 | |
| 2020-07-10 |
Trident Acquisitions Corp. TDAC |
S, Open-market sale | 13,143 disposed | 10.92 | 143,521.56 | Form 4, filing 0001393825-20-000123 | |
| 2020-03-25 |
Amci Acquisition Corp. AMCI |
P, Open-market purchase | 384,300 acquired | 10.15 | 3,900,645.00 | Form 4, filing 0001393825-20-000101 | |
| 2020-03-24 |
SCVX Corp. SCVX |
P, Open-market purchase | 38,925 acquired | Not reported | Not priced | Form 4, filing 0001393825-20-000100 | |
| 2020-03-23 |
SCVX Corp. SCVX |
P, Open-market purchase | 892,024 acquired | Not reported | Not priced | Form 4, filing 0001801041-20-000001 | |
| 2020-03-20 |
Tenzing Acquisition Corp. TZAC |
P, Open-market purchase | 10,000 acquired | 10.37 | 103,700.00 | Form 4, filing 0001393825-20-000131 | |
| 2020-03-19 |
SCVX Corp. SCVX |
P, Open-market purchase | 300,000 acquired | Not reported | Not priced | Form 4, filing 0001801041-20-000001 | |
| 2020-03-19 |
SCVX Corp. SCVX |
P, Open-market purchase | 140,200 acquired | Not reported | Not priced | Form 4, filing 0001801041-20-000001 | |
| 2020-02-28 |
Akers Biosciences, Inc. AKER |
S, Open-market sale | 638 disposed | 2.81 | 1,792.78 | Form 4, filing 0001393825-20-000097 | |
| 2020-02-27 |
Akers Biosciences, Inc. AKER |
S, Open-market sale | 15,300 disposed | 2.72 | 41,616.00 | Form 4, filing 0001393825-20-000096 | |
| 2020-02-25 |
Akers Biosciences, Inc. AKER |
S, Open-market sale | 13,000 disposed | 2.92 | 37,960.00 | Form 4, filing 0001393825-20-000096 | |
| 2020-01-24 |
SCVX Corp. SCVX |
P, Open-market purchase | 1,000,000 acquired | Not reported | Not priced | Form 4, filing 0001213900-20-001995 | |
| 2019-12-20 |
Akers Biosciences, Inc. AKER |
P, Open-market purchase | 8,000 acquired | 3.02 | 24,160.00 | Form 4, filing 0001393825-20-000002 | |
| 2019-12-19 |
Akers Biosciences, Inc. AKER |
P, Open-market purchase | 2,700 acquired | 3.08 | 8,316.00 | Form 4, filing 0001393825-20-000002 | |
| 2019-12-18 |
Akers Biosciences, Inc. AKER |
P, Open-market purchase | 7,500 acquired | 3.07 | 23,025.00 | Form 4, filing 0001393825-20-000002 | |
| 2019-12-17 |
Akers Biosciences, Inc. AKER |
P, Open-market purchase | 3,000 acquired | 3.03 | 9,090.00 | Form 4, filing 0001393825-20-000002 | |
| 2019-12-16 |
Akers Biosciences, Inc. AKER |
P, Open-market purchase | 5,000 acquired | 3.07 | 15,350.00 | Form 4, filing 0001393825-20-000002 | |
| 2019-12-13 |
Akers Biosciences, Inc. AKER |
P, Open-market purchase | 6,000 acquired | 3.02 | 18,120.00 | Form 4, filing 0001393825-20-000002 | |
| 2019-12-12 |
Akers Biosciences, Inc. AKER |
P, Open-market purchase | 20,600 acquired | 2.98 | 61,388.00 | Form 4, filing 0001393825-20-000002 | |
| 2019-12-11 |
Akers Biosciences, Inc. AKER |
P, Open-market purchase | 26,406 acquired | 3.10 | 81,858.60 | Form 4, filing 0001393825-20-000002 | |
| 2019-12-11 |
Akers Biosciences, Inc. AKER |
P, Open-market purchase | 6,019 acquired | 3.05 | 18,357.95 | Form 4, filing 0001393825-20-000002 | |
| 2019-12-10 |
Akers Biosciences, Inc. AKER |
P, Open-market purchase | 30,000 acquired | 2.97 | 89,100.00 | Form 4, filing 0001393825-20-000002 | |
| 2019-12-09 |
Akers Biosciences, Inc. AKER |
P, Open-market purchase | 19,353 acquired | 2.96 | 57,284.88 | Form 4, filing 0001393825-20-000002 | |
| 2019-12-09 |
Akers Biosciences, Inc. AKER |
P, Open-market purchase | 50,000 acquired | 2.99 | 149,500.00 | Form 4, filing 0001393825-20-000002 | |
| 2018-09-14 |
Longevity Acquisition Corp LOACU |
S, Open-market sale | 25,000 acquired | 10.23 | 255,750.00 | Form 4, filing 0001393825-18-000063 | |
| 2018-09-13 |
Longevity Acquisition Corp LOACU |
S, Open-market sale | 20,000 disposed | 10.20 | 204,000.00 | Form 4, filing 0001393825-18-000062 | |
| 2018-09-11 |
Longevity Acquisition Corp LOACU |
S, Open-market sale | 20,000 disposed | 10.19 | 203,800.00 | Form 4, filing 0001393825-18-000062 | |
| 2018-07-12 |
M I Acquisitions, Inc. MACQ |
S, Open-market sale | 160,000 disposed | 10.60 | 1,696,000.00 | Form 4, filing 0000902664-18-002833 | |
| 2018-07-10 |
M I Acquisitions, Inc. MACQ |
S, Open-market sale | 207 disposed | 10.60 | 2,194.20 | Form 4, filing 0000902664-18-002833 | |
| 2018-07-09 |
M I Acquisitions, Inc. MACQ |
S, Open-market sale | 37,500 disposed | 10.60 | 397,500.00 | Form 4, filing 0000902664-18-002833 | |
| 2017-02-08 |
Galena Biopharma, Inc. GALE |
S, Open-market sale | 2,363,441 disposed | 0.84 | 1,985,290.44 | Form 4, filing 0000902664-17-001037 | |
| 2015-10-15 |
Hc2 Holdings, Inc. HCHC |
S, Open-market sale | 522,000 disposed | 7.50 | 3,915,000.00 | Form 4, filing 0000902664-15-003963 | |
| 2015-10-12 |
Hc2 Holdings, Inc. HCHC |
S, Open-market sale | 62,500 disposed | 7.93 | 495,787.50 | Form 4, filing 0000902664-15-003907 | |
| 2015-10-09 |
Hc2 Holdings, Inc. HCHC |
S, Open-market sale | 25,000 disposed | 7.65 | 191,262.50 | Form 4, filing 0000902664-15-003907 | |
| 2013-05-09 |
24Holdings Inc TWFH |
P, Open-market purchase | 344,210 acquired | 0.19 | 66,983.27 | Form 4, filing 0001393825-13-000040 | |
| 2013-05-09 |
24Holdings Inc TWFH |
P, Open-market purchase | 344,210 acquired | 0.19 | 66,983.27 | Form 4, filing 0001393825-13-000037 | |
| 2009-10-05 |
EnteroMedics Inc ETRM |
S, Open-market sale | 196,774 disposed | 0.92 | 180,638.53 | Form 4, filing 0000902664-09-003665 | |
| 2009-10-02 |
EnteroMedics Inc ETRM |
S, Open-market sale | 2,234,329 disposed | 1.02 | 2,267,843.94 | Form 4, filing 0000902664-09-003665 | |
| 2008-07-23 |
Chem RX Corp CHRX |
S, Open-market sale | 736,999 disposed | 5.99 | 4,414,845.11 | Form 4, filing 0000902664-08-002406 | |
| 2008-07-22 |
Chem RX Corp CHRX |
S, Open-market sale | 700,000 disposed | 5.99 | 4,193,210.00 | Form 4, filing 0000902664-08-002406 | |
| 2007-12-03 |
Chem RX Corp PMQC |
S, Open-market sale | 1,000 disposed | 6.45 | 6,450.00 | Form 4, filing 0000902664-07-003491 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 1
- Open-market sale 0
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Hudson Bay Capital Management LP, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001393825
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6